1. End-point diagnostics of Giardia duodenalis assemblages A and B by combining RPA with CRISPR/Cas12a from human fecal samples.
- Author
-
Wang Y, Yu F, Fu Y, Zhang Q, Zhao J, Qin Z, Shi K, Wu Y, Li J, Li X, and Zhang L
- Subjects
- Humans, Nucleic Acid Amplification Techniques methods, Limit of Detection, Giardia lamblia genetics, Giardia lamblia isolation & purification, Giardia lamblia classification, Giardiasis diagnosis, Giardiasis parasitology, Feces parasitology, CRISPR-Cas Systems, Sensitivity and Specificity
- Abstract
Background: Giardia duodenalis is a common enteric protozoan parasite that is categorized into eight assemblages (A-H). In particular, assemblages A and B are zoonotic, capable of infecting both humans and animals worldwide, resulting in significant economic losses and public health challenges in epidemic regions. Thus, the development of rapid, accurate and non-laboratory-based diagnostic methods for infected animals is crucial for the effective prevention and control of giardiasis. Recent advancements in clustered, regularly interspaced, short palindromic repeats (CRISPR) and CRISPR-associated (Cas) protein (Cas12a) systems allow promising avenues for nucleic acid detection, characterized by their high flexibility, sensitivity and specificity., Methods: Combined recombinase polymerase amplification and CRISPR/Cas12a systems were combined and used as end-point diagnostic methods (termed REPORT) to detect G. duodenalis assemblage A and B. The diagnostic results can be observed by fluorescence readouts with the naked eye under blue light or colorimetric signals using a lateral flow strip (LFS)., Results: The limit of detection (LOD) of the REPORT‑based G. duodenalis assemblage A detection was 2.04 CFU/ml and 10 trophozoites per gram (TPG), and the LOD of assemblage B was 1.1 CFU/ml and 10 cysts per gram (CPG). The REPORT‑based G. duodenalis assemblage A and assemblage B detection methods have strong specificity and no cross-reactivity with other assemblages of G. duodenalis or common enteric parasitic protozoa and have excellent performance in clinical sample detection., Conclusions: This study presents a novel strategy for the direct identification of G. duodenalis assemblages A and B, requiring neither highly trained personnel nor costly specialized equipment., Competing Interests: Declarations Ethics approval and consent to participate All the research procedures used in this study were approved by the Institutional Review Board of Henan Agricultural University (approval no. IRB-HENAU-20190820-02). The use of positive human samples in this study complied with the 1975 Declaration of Helsinki, as revised in 2013. Consent for publication Not applicable. Competing interests The authors declare no competing interests., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF